Narrow search
Showing 1 - 10 of 49
Cover Image
Consequences of the TRIPS-Agreement for the provision of pharmaceuticals in developing countries
Oppermann, Julia - 2008
Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS … Arzneimittel gegen vernachlässigte Krankheiten bis zum 30.06.2008 überprüft. Unter Berücksichtigung des kurzfristigen …
Persistent link: https://www.econbiz.de/10009475357
Cover Image
Markteintritt deutscher KMU in Japan ? eine theoretische und empirische Analyse anhand der Medizintechnikindustrie
Toto, Serkan - 2009
Die japanische Wirtschaft steht seit Jahrzehnten im Ruf, ein verschlossener Markt mit hohen Handelsh?rden zu sein. Dazu ger?t Japan im Zuge der Hinwendung deutscher Firmen nach China in der Wahrnehmung der ?ffentlichkeit zunehmend in den Hintergrund. Insbesondere deutsche Mittelstandsunternehmen...
Persistent link: https://www.econbiz.de/10009485594
Cover Image
Assessing Quality Improvement Infrastructure in the Formation of Accountable Care Organizations: A Regional Policy Analysis for the Pharmaceutical Industry
Carr-Whealy, Nathan - 2011
Accountable Care Organizations are developing in the United States as a result of the Patient Protection and Affordable Care Act. A study is needed to evaluate an emerging issue of ACOs, quality improvement infrastructure, and the pharmaceutical industry. The convergence of these topics has not...
Persistent link: https://www.econbiz.de/10009434765
Cover Image
OS NOVOS RUMOS DA ESTRATÉGIA DE MARKETING NO MERCADO FARMACÊUTICO
Correa, Gisleine Fregoneze; Oliveira, Luciel Henrique de - 2008
The pharmaceutical industry invests its sales force in contacts with doctors, making visits and publicizing its drugs, in orderfor them to prescribe these products to their patients. This work discusses the structure of the pharmaceutical market and howmarketing strategies are used by...
Persistent link: https://www.econbiz.de/10009446936
Cover Image
Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act
Grabowski, Henry; Vernon, John - 1992
IN 1984, Congress enacted a new law that greatly affected the economicsof the pharmaceutical industry in the United States. It has been characterizedas the most important legislation affecting competition in the pharmaceuticalindustry since the 1962 Kefauver-Harris Amendments to theFood and Drug...
Persistent link: https://www.econbiz.de/10009475542
Cover Image
Substitution laws and innovation in the pharmaceutical industry.
Grabowski, Henry; Vernon, John - 1979
innovation process through the distribution and marketing of pharmaceuticals. In contrast to other products, drugs can be …
Persistent link: https://www.econbiz.de/10009475544
Cover Image
Precedence of institutions over research environment in determining growth in Uttar Pradesh in India
Panda, Hrushikesh - 2008
has a conducive research environment for development ofdrugs and pharmaceuticals industry with many central government … organizations carryingout research related to the industry. Drugs and pharmaceuticals is a research intensiveindustry. In a … Pradeshshould be in a position to attract investment into the drugs and pharmaceuticals industry.However, it is observed that there …
Persistent link: https://www.econbiz.de/10009475795
Cover Image
Valuing Water - A Globally Sustainable Approach for the Pharmaceutical Industry
Donnelly, Kristina; Dorau, Therese; Koslow, Melinda; … - 2008
Water resources around the globe are at risk from expanding demand and decreasedavailability. All sectors of society rely on water for operation – agriculture, industry, powergeneration, and domestic users all require a constant, clean supply. As a result of populationgrowth and environmental...
Persistent link: https://www.econbiz.de/10009476746
Cover Image
Novartis and the United Nations Global Compact Initiative
Tavis, Lee A. - 2002
The spirit of the Global Compact found fertile ground and has become an integral part of Novartis corporate strategy since the enterprise was formed by the merger of the two large Swiss pharmaceutical companies, Sandoz and Ciba, in 1996. Following a four-year concentration on economic...
Persistent link: https://www.econbiz.de/10009476845
Cover Image
Prescription drug samples: Does this marketing strategy counteract policies for quality use of medicines?
Groves, K. E. M.; Sketris, I.; Tett, S. E. - 2003
Prescription drug samples, as used by the pharmaceutical industry to market their products, are of current interest because of their influence on prescribing, and their potential impact on consumer safety. Very little research has been conducted into the use and misuse of prescription drug...
Persistent link: https://www.econbiz.de/10009448631